Corrigendum to 'Pharmacodynamic analysis of intravenous bolus remimazolam for loss of consciousness in patients undergoing general anaesthesia: a randomised, prospective, double-blind study' (Br J Anaesth 2022; 129: 49-57)
- PMID: 36075773
- DOI: 10.1016/j.bja.2022.08.010
Corrigendum to 'Pharmacodynamic analysis of intravenous bolus remimazolam for loss of consciousness in patients undergoing general anaesthesia: a randomised, prospective, double-blind study' (Br J Anaesth 2022; 129: 49-57)
Erratum for
-
Pharmacodynamic analysis of intravenous bolus remimazolam for loss of consciousness in patients undergoing general anaesthesia: a randomised, prospective, double-blind study.Br J Anaesth. 2022 Jul;129(1):49-57. doi: 10.1016/j.bja.2022.02.040. Epub 2022 May 11. Br J Anaesth. 2022. PMID: 35562226 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources